Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 1
2009 1
2010 1
2011 1
2013 1
2014 3
2015 2
2016 2
2017 1
2019 1
2020 1
2021 9
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Ultrafast 30-min infusion of a rituximab biosimilar (Truxima).
Pérez-Persona E, Cuevas Palomares L, Unamunzaga Cilaurren A, Gutiérrez López de Ocáriz X, Buendía Ureña B, Vega González de Viñaspre A, Benito Ibarrondo B, Molinillo Fernández MC, Cordero Osúa A, Benítez Delgado B, García Albás JJ, Andrés Moralejo MÁ, Guinea de Castro JM. Pérez-Persona E, et al. EJHaem. 2023 Oct 17;4(4):1196-1199. doi: 10.1002/jha2.812. eCollection 2023 Nov. EJHaem. 2023. PMID: 38024594 Free PMC article.
Treatment burden in multiple myeloma according to comorbidity in real life.
Pérez Persona E, Oiartzabal Ormategui I, Cuevas Palomares L, Santamaría López A, Robles de Castro D, Miguel de Sánchez C, Gabilondo Jalón M, Pisón Herrero C, Unamunzaga Cilaurren A, Vega González de Viñaspre A, Guinea de Castro JM. Pérez Persona E, et al. Ann Hematol. 2022 Feb;101(2):437-440. doi: 10.1007/s00277-021-04462-7. Epub 2021 Mar 5. Ann Hematol. 2022. PMID: 33674939 No abstract available.
Primary plasma cell leukaemia presenting with flower-shaped nuclei.
De Miguel Sánchez C, Robles de Castro D, Pisón Herrero C, Pérez Persona E, Salcedo Cuesta L, Guinea de Castro JM. De Miguel Sánchez C, et al. Among authors: perez persona e. Br J Haematol. 2021 May;193(4):689. doi: 10.1111/bjh.17320. Epub 2021 Feb 22. Br J Haematol. 2021. PMID: 33618433 No abstract available.
Velcadito: Low dose of bortezomib with melphalan and prednisone for ≥75-year-olds newly diagnosed with multiple myeloma.
Pérez-Persona E, Oiartzabal-Ormategui I, Herraez S, Menchaca C, Cuevas-Palomares L, Santamaría-López A, Díez-Angulo R, Robles-Castro D, de Miguel-Sánchez C, Gabilondo-Jalón M, Pisón-Herrero C, Unamunzaga-Cilaurren A, Vega González-Viñaspre A, Salcedo-Cuesta L, Mendizabal-Abad A, Guinea de Castro JM. Pérez-Persona E, et al. Eur J Haematol. 2022 Jun;108(6):532-535. doi: 10.1111/ejh.13760. Epub 2022 Mar 7. Eur J Haematol. 2022. PMID: 35194853 No abstract available.
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies.
Tamariz-Amador LE, Battaglia AM, Maia C, Zherniakova A, Guerrero C, Zabaleta A, Burgos L, Botta C, Fortuño MA, Grande C, Manubens A, Arguiñano JM, Gomez C, Perez-Persona E, Olazabal I, Oiartzabal I, Panizo C, Prosper F, San-Miguel JF, Rodriguez-Otero P, Martín-Sánchez E, Paiva B; The Asociación Vasco-Navarra de Hematología y Hemoterapia (ASOVASNA) Cooperative Group. Tamariz-Amador LE, et al. Among authors: perez persona e. Blood Cancer J. 2021 Dec 14;11(12):202. doi: 10.1038/s41408-021-00594-1. Blood Cancer J. 2021. PMID: 34907159 Free PMC article.
Pylephlebitis: incidence and prognosis in a tertiary hospital.
Belhassen-García M, Gomez-Munuera M, Pardo-Lledias J, Velasco-Tirado V, Perez-Persona E, Galindo-Perez I, Alvela-Suárez L, Romero-Alegría A, Muñoz-Bellvis L, Cordero-Sánchez M. Belhassen-García M, et al. Among authors: perez persona e. Enferm Infecc Microbiol Clin. 2014 Jun-Jul;32(6):350-4. doi: 10.1016/j.eimc.2013.09.002. Epub 2014 May 17. Enferm Infecc Microbiol Clin. 2014. PMID: 24844192
Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).
González-Rincón J, Garcia-Vela JA, Gómez S, Fernández-Cuevas B, Nova-Gurumeta S, Pérez-Sanz N, Alcoceba M, González M, Anguita E, López-Jiménez J, González-Barca E, Yáñez L, Pérez-Persona E, de la Serna J, Fernández-Zarzoso M, Deben G, Peñalver FJ, Fernández MC, de Oteyza JP, Andreu MÁ, Ruíz-Guinaldo MÁ, Paz-Arias R, García-Malo MD, Recasens V, Collado R, Córdoba R, Navarro-Matilla B, Sánchez-Beato M, García-Marco JA. González-Rincón J, et al. Among authors: perez persona e. PLoS One. 2021 Sep 10;16(9):e0257353. doi: 10.1371/journal.pone.0257353. eCollection 2021. PLoS One. 2021. PMID: 34506616 Free PMC article.
Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience.
Rodriguez-Otero P, Sirvent M, González-Rodríguez AP, Lavilla E, de Coca AG, Arguiñano JM, Martí JM, Cabañas V, Motlló C, de Cabo E, Encinas C, Murillo I, Hernández-Rivas JÁ, Pérez-Persona E, Casado F, Sampol A, García R, Blanchard MJ, Anguita M, Lafuente AP, Iñigo B, López A, Ribas P, Arnao M, Maldonado R, Bladé J, Mateos MV, Lahuerta JJ, San Miguel JF. Rodriguez-Otero P, et al. Among authors: perez persona e. Clin Lymphoma Myeloma Leuk. 2021 Jun;21(6):413-420. doi: 10.1016/j.clml.2021.02.004. Epub 2021 Feb 16. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33741302
28 results